Lupin receives US FDA approval for its generic cancer drug
Indian pharma major Lupin announced that the US Food and Drug Administration has approved its abbreviated new drug application for Lenalidomide capsules in strengths of 2.5 mg to 25 mg…
Anti-trust lawsuit against Natco Pharma over generic cancer drug dismissed in US
Natco Pharma on December 21 said anti-trust claims against it regarding a generic cancer treatment drug in the US have been dismissed. In September this year, the company had stated…







